Cardiovascular Journal最新文献_第6页

A Young Girl with Barely Symptomatic Congenital Mitral Valve Disease 一个年轻女孩几乎没有症状的先天性二尖瓣疾病

Cardiovascular Journal Pub Date : 2021-09-15 DOI: 10.3329/cardio.v14i1.55380

G. Paul, Muhammad Ahsan khan, Mohammad Abdus Sattar Bhuiyan, M. A. Sharker, Jahir Uddin Mohammed Sharif, N. Jahan, Koushik Bhowmick, Md. Shamim Chowdhury

引用次数: 0

Huge Left Atrial Aneurysm: First Case Report in Bangladesh 巨大左心房动脉瘤:孟加拉首例报告

Cardiovascular Journal Pub Date : 2021-09-15 DOI: 10.3329/cardio.v14i1.55377

N. Fatema, S. Prabhu

引用次数: 0

Amiodarone in the Management of Cardiac Arrhythmia Following Open Heart Surgery 胺碘酮在心脏直视手术后心律失常治疗中的应用

Cardiovascular Journal Pub Date : 2021-09-15 DOI: 10.3329/cardio.v14i1.55369

N. Hosain, Rajibul Islam, Muhammad Abdul Quaium Chowdhury, Mohammad Fazle Maruf, A. Mahmud, M. R. Chowdhury, Maruf Hasan Alam Arnob, Fahmida Hoque

{"title":"Amiodarone in the Management of Cardiac Arrhythmia Following Open Heart Surgery","authors":"N. Hosain, Rajibul Islam, Muhammad Abdul Quaium Chowdhury, Mohammad Fazle Maruf, A. Mahmud, M. R. Chowdhury, Maruf Hasan Alam Arnob, Fahmida Hoque","doi":"10.3329/cardio.v14i1.55369","DOIUrl":"https://doi.org/10.3329/cardio.v14i1.55369","url":null,"abstract":"Background: Postoperative cardiac arrhythmias may present as life threatening complications like- cerebrovascular strokes, thrombo-embolic manifestations, inadequate ventricular filling and compromised hemodynamic stability. Amiodarone is an effective drug for various postoperative arrhythmias. Objective of this study is to evaluate the efficacy of Amiodarone in controlling postoperative arrhythmia in our settings at the department of cardiac surgery.\u0000Methods: This retrospective observational study involved random selection of 20 patients, who developed potentially life-threatening arrhythmia following cardiac surgical procedures under cardiopulmonary bypass (CPB) at Chittagong Medical College Hospital (CMCH) between January 2018 and December 2020. Amiodarone was used in controlling postoperative cardiac arrhythmia by loading 1000 mg in first 24 hours, followed by 800 mg orally in daily divided doses.\u0000Results: Among 20 patients under study, five had valvular replacement, three had ASD closure, one VSD closure, one patient had excision of LA myxoma and in ten patients had undergone CABG. The Mean ± SD of the age of the patients was 50.2 ± 14.7 years. Eleven patients (55%) were female. Atrial fibrillation with rapid ventricular rate occurred in 15 patients, supraventricular tachycardia in two and ventricular tachycardia three patients. Targets were achieved in all 20 of these patients. Among them 13 (65%) reverted to sinus rhythm, in other 7 AF persisted but ventricular rates became below 100/m with hemodynamic stability. The Mean ± SD of the time required for target achievement was 8.9 ± 7.4 hours. There was no perioperative death in these patients.\u0000Conclusion: Amiodarone is an effective medication in combating both atrial and ventricular arrhythmia following cardiac surgery employing cardiopulmonary bypass.\u0000Cardiovasc j 2021; 14(1): 20-23","PeriodicalId":9438,"journal":{"name":"Cardiovascular Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90354390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Vascular Duplex Study: A Historical Perspective 血管双工研究:一个历史的视角

Cardiovascular Journal Pub Date : 2021-09-15 DOI: 10.3329/CARDIO.V14I1.55375

A. Bashar

引用次数: 0

Fatema’s Basic Paediatric Cardiology, 2nd Edition 法蒂玛基础儿科心脏病学，第二版

Cardiovascular Journal Pub Date : 2021-09-15 DOI: 10.3329/cardio.v14i1.55384

Abma Salam, HM Mozammel

引用次数: 1

Coronary Artery Diseases During Pregnancy: Minimizing Adverse Consequences and Improving Clinical Outcome 妊娠期间冠状动脉疾病:减少不良后果和改善临床结果

Cardiovascular Journal Pub Date : 2021-09-15 DOI: 10.3329/cardio.v14i1.55376

Nadira Haque, N. Hosain, A. Islam, Zakia Mamataz, M. Ibrahim, Shamim, Ahmed, M. Anisuzzaman, Shahena Akter

{"title":"Coronary Artery Diseases During Pregnancy: Minimizing Adverse Consequences and Improving Clinical Outcome","authors":"Nadira Haque, N. Hosain, A. Islam, Zakia Mamataz, M. Ibrahim, Shamim, Ahmed, M. Anisuzzaman, Shahena Akter","doi":"10.3329/cardio.v14i1.55376","DOIUrl":"https://doi.org/10.3329/cardio.v14i1.55376","url":null,"abstract":"Coronary artery disease in pregnancy is a catastrophic situation that may endanger the lives of both the mother and the fetus. Cardiac diseases may account for up to 15% of maternal mortality. Pregnancy may increase the risk of acute myocardial infarction up to 4-fold. Various hemodynamic derangements may occur during pregnancy including expansion of plasma and blood volume, compression of inferior vena cava and fall in both systemic and pulmonary vascular resistances. If pregnant women present with acute coronary artery disease, medical management should be attempted first and if any intervention or surgery is needed, efforts must be made to lower the risk. A multidisciplinary approach is essential involving obstetrician, cardiologist, cardiac surgeons, anesthesiologist and neonatologists or pediatrician. Pregnancy is considered to be a relative contraindication to thrombolytic therapy due to some complications. Revascularization may be considered in acute coronary syndrome in pregnant women like other nonpregnant patients. Primary per cutaneous coronary intervention or coronary artery bypass graft have been performed successfully during pregnancy and may be considered as therapeutic option in pregnancy in selective cases. Percutaneous coronary intervention (PCI) is considered to be relatively safe for maternal and fetal survival during pregnancy. Main worry in PCI is radiation exposure and need to dual antiplatelet therapy. Bare metal stent is preferred during pregnancy because of shorter duration of anticoagulation therapy. Early second trimester is the optimum surgical period to coronary artery bypass surgery (CABG) in pregnant women. Coronary artery bypass surgery can be safely done after 28 weeks of gestational age and immediately after cesarean section. Early detection, a multidisciplinary approach and timely interventions must be considered in coronary artery disease in pregnancy for better obstetric outcome.\u0000Cardiovasc j 2021; 14(1): 61-69","PeriodicalId":9438,"journal":{"name":"Cardiovascular Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74956873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Echocardiographic Profile of Hypertrophic Cardiomyopathy – A Single-Centre, Observational study 肥厚性心肌病的超声心动图特征-一项单中心观察研究

Cardiovascular Journal Pub Date : 2021-09-15 DOI: 10.3329/cardio.v14i1.55367

A. Islam, D. Adhikary, Shovan Rahman, Mohsin Ahmed, Md. Toufiqur Rahman, M. Ullah, A. Majumder

{"title":"Echocardiographic Profile of Hypertrophic Cardiomyopathy – A Single-Centre, Observational study","authors":"A. Islam, D. Adhikary, Shovan Rahman, Mohsin Ahmed, Md. Toufiqur Rahman, M. Ullah, A. Majumder","doi":"10.3329/cardio.v14i1.55367","DOIUrl":"https://doi.org/10.3329/cardio.v14i1.55367","url":null,"abstract":"Background: Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease of left ventricular hypertrophy (LVH). Phenotypic expression varies widely from subclinical hypertrophy to gross asymmetric septal hypertrophy causing left ventricular outflow tract (LVOT) obstruction. On top of genetic and phenotypic heterogeneity, the prevalence of different types of HCM may have geographical, as well as, ethnic variation.\u0000Methods: This observational study was carried out during 2010 to 2020 to determine the echocardiographic profile of HCM in Bangladeshi population. All patients undergoing transthoracic echocardiography (TTE) in a private consultation centre of Dhaka, Bangladesh were included. HCM was defined as the presence of a maximal end-diastolic wall thickness of e”15 mm anywhere in the left ventricle (LV), in the absence of another cause of hypertrophy in adults. HCM was further classified according to the pattern of myocardial hypertrophy and presence or absence of LVOT, or mid-left ventricular cavity obstruction.\u0000Results: Out of 76 cases, non-obstructive HCM was the commonest type (65.8%), followed by HCM causing LVOT obstruction (13.2%), HCM causing mid-LV cavity obstruction (10.5%), and the apical variety ( 10.5%). Asymmetric septal hypertrophy (ASH) was found in 42.1%, systolic anterior motion (SAM) of anterior mitral leaflet (AML) in 14.5%, mitral regurgitation (MR) in 50%, left ventricular systolic dysfunction in 5.3%, and raised pulmonary artery systolic pressure (PASP) in 15.8% of cases. Maximum LV wall thickness ≥30 mm was found in 66 out of 76 cases.\u0000Conclusion: The study highlights the clinically useful profile of HCM in Bangladeshi population based on conventional echocardiography. Further studies involving clinical, newer echocardiographic modalities and genetic analyses are warranted to discover the additional information in this ethnicity.\u0000Cardiovasc j 2021; 14(1): 5-11","PeriodicalId":9438,"journal":{"name":"Cardiovascular Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83054457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

John W Kirklin: The Greatest Scientific Cardiac Surgeon of the Century 约翰·W·柯克林:本世纪最伟大的科学心脏外科医生

Cardiovascular Journal Pub Date : 2021-09-15 DOI: 10.3329/cardio.v14i1.55383

Anisuzzaman, N. Hosain

引用次数: 0

Appearance can be Deceptive- A Case Report on Central Venous Line Complication 外表可能具有欺骗性——中心静脉管并发症1例报告

Cardiovascular Journal Pub Date : 2021-09-15 DOI: 10.3329/cardio.v14i1.55378

Mohammod Ali, F. Khan, Sudhakar Sarker, A. Bashar, A. Chowdhury

引用次数: 0

Heart Failure: Insights into Device Therapy 心力衰竭:器械治疗的见解

Cardiovascular Journal Pub Date : 2021-09-15 DOI: 10.3329/cardio.v14i1.55366

Abdul Kader Akanda

引用次数: 0